Differential inhibition of cyclooxygenases 1 and 2 by NSAIDs

This publication has 52 references indexed in Scilit:

• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
  Published by Elsevier ,2002
• Safety of Meloxicam: A Global Analysis of Clinical Trials
  Rheumatology, 1996
• A 4-Week, Double-Blind, Parallel-Group Study to Compare the Gastrointestinal Effects of Meloxicam 7.5 mg, Meloxicam 15 mg, Piroxicam 20 mg and Placebo by Means of Faecal Blood Loss, Endoscopy and Symptom Evaluation in Healthy Volunteers
  Rheumatology, 1996
• Meloxicam: A potent inhibitor of adjuvant arthritis in the Lewis rat
  Inflammation Research, 1995
• Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
  Nature, 1995
• Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance
  Inflammation Research, 1995
• A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2)
  Inflammation Research, 1995
• Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors
  Inflammation Research, 1995
• Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
• The Relative Abundance of Type 1 to Type 2 Cyclo-oxygenase mRNA in Human Amnion at Term
  Biochemical and Biophysical Research Communications, 1994